Therapeutic potential of sulfamides as enzyme inhibitors

被引:182
作者
Winum, Jean-Yves
Scozzafava, Andrea
Montero, Jean-Lonis
Supuran, Claudiu T.
机构
[1] Univ Florence, Dipartimento Chim, Lab Chim Bioinorgan, I-50019 Florence, Italy
[2] Univ Montpellier 2, Lab Chim Biomol, UMR 5032, Ecole Natl Super Chim, F-34296 Montpellier, France
关键词
sulfamide; enzyme-inhibitor adduct; protease inhibitors; carbonic anhydrase inhibitors; steroid sulfatase inhibitors; HIV protease; gamma-secretase; elastase; chymase; tryptase; thrombin; carboxypeptidase A; matrix metalloproteinase; protein tyrosine phosphatase;
D O I
10.1002/med.20068
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Sulfamide, a quite simple molecule incorporating the sulfonamide functionality, widely used by medicinal chemists for the design of a host of biologically active derivatives with pharmacological applications, may give rise to at least five types of derivatives, by substituting one to four hydrogen atoms present in it, which show specific biological activities. Recently, some of these compounds started to be exploited for the design of many types of therapeutic agents. Among the enzymes for which sulfamide-based inhibitors were designed, are the carbonic anhydrases (CAs), a large number of proteases belonging to the aspartic protease (HIV-1 protease, gamma-secretase), serine protease (elastase, chymase, tryptase, and thrombin among others), and metalloprotease (carboxypeptidase A (CPA) and matrix metalloproteinases (MMP)) families. Some steroid sulfatase (STS) and protein tyrosine phosphatase inhibitors belonging to the sulfamide class of derivatives have also been reported. In all these compounds, many of which show low nanomolar affinity for the target enzymes for which they have been designed, the free or substituted sulfamide moiety plays important roles for the binding of the inhibitor to the active site cavity, either by directly coordinating to a metal ion found in some metalloenzymes (CAs, CPA, STS), usually by means of one of the nitrogen atoms present in the sulfamide motif, or as in the case of the cyclic sulfamides acting as HIV protease inhibitors, interacting with the catalytically critical aspartic acid residues of the active site by means of an oxygen atom belonging to the HN-SO2-NH motif, which substitutes a catalytically essential water molecule. In other cases, the sulfamide moiety is important for inducing desired physico-chemical properties to the drug-like compounds incorporating it, such as enhanced water solubility, better bioavailability, etc., because of the intrinsic properties of this highly polarized moiety when attached to an organic scaffold. This interesting motif is thus of great value for the design of pharmacological agents with a lot of applications. (c) 2006 Wiley Periodicals, Inc.
引用
收藏
页码:767 / 792
页数:26
相关论文
共 107 条
[1]   Nonaromatic sulfonamide group as an ideal anchor for potent human carbonic anhydrase inhibitors: Role of hydrogen-bonding networks in ligand binding and drug design [J].
Abbate, F ;
Supuran, CT ;
Scozzafava, A ;
Orioli, P ;
Stubbs, MT ;
Klebe, G .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (17) :3583-3587
[2]  
ALA PJ, 2002, PROTEINASE PEPTIDASE, P367
[3]  
[Anonymous], PROTEASE INHIBITORS
[4]  
[Anonymous], PROTEASE INHIBITORS
[5]  
ASTRAZENECA, 2004, Patent No. 2004050646
[6]   Unexpected binding mode of a cyclic sulfamide HIV-1 protease inhibitor [J].
Backbro, K ;
Lowgren, S ;
Osterlund, K ;
Atepo, J ;
Unge, T ;
Hulten, J ;
Bonham, NM ;
Schaal, W ;
Karlen, A ;
Hallberg, A .
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (06) :898-902
[7]   Highly active antiretroviral therapy: Current state of the art, new agents and their pharmacological interactions useful for improving therapeutic outcome [J].
Barbaro, G ;
Scozzafava, A ;
Mastrolorenzo, A ;
Supuran, CT .
CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (14) :1805-1843
[8]   Structure-based design of protein tyrosine phosphatase-1B inhibitors [J].
Black, E ;
Breed, J ;
Breeze, AL ;
Embrey, K ;
Garcia, R ;
Gero, TW ;
Godfrey, L ;
Kenny, PW ;
Morley, AD ;
Minshull, CA ;
Pannifer, AD ;
Read, J ;
Rees, A ;
Russell, DJ ;
Toader, D ;
Tucker, J .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (10) :2503-2507
[9]   Carbonic anhydrase activators: X-ray crystallographic and spectroscopic investigations for the interaction of isozymes I and II with histamine [J].
Briganti, F ;
Mangani, S ;
Orioli, P ;
Scozzafava, A ;
Vernaglione, G ;
Supuran, CT .
BIOCHEMISTRY, 1997, 36 (34) :10384-10392
[10]   Carbonic anhydrase inhibitors .37. Novel classes of isozyme I and II inhibitors and their mechanism of action. Kinetic and spectroscopic investigations on native and cobalt-substituted enzymes [J].
Briganti, F ;
Pierattelli, R ;
Scozzafava, A ;
Supuran, CT .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1996, 31 (12) :1001-1010